肝前性门脉高压症血管腔内治疗体会  

Experience in the intracavitary therapy for prehepatic portal hypertension

作　　者：公强 于凌 罗晓苗 张希全[2] GONG Qiang;YU Ling;LUO Xiaomiao;ZHANG Xiquan(Department of Medical Imaging,Weifang Medical University,Weifang 261053,China;Endovascular Interventional Diagnosis and Treatment Center,the 960th Hospital of Chinese People’s Liberation Army)

机构地区：[1]潍坊医学院医学影像学系,山东潍坊261053 [2]中国人民解放军第960医院全军腔内介入诊疗中心

出　　处：《潍坊医学院学报》2019年第4期305-307,310,共4页Acta Academiae Medicinae Weifang

摘　　要：目的评价腔内治疗肝前性门脉高压(PPH)的有效性和安全性。方法 2008年1月~2018年2月对19例肝前性门脉高压行介入治疗,行经皮经肝或经皮经脾穿刺门静脉并置入支架,必要时利用弹簧圈栓塞胃底食管曲张静脉。结果 12例患者采用经皮经肝途径,7例采用经皮经脾途径。患者经腔内治疗后出血停止,部分患者出现发热、腹痛等不良反应,对症治疗后多在7~14d内改善。19例患者均采用球囊扩张门静脉主干并成功置入支架。通过随访患者生存期及生存质量,较未行腔内治疗患者生存期明显延长,生存质量明显提高。结论血管腔内治疗肝前性门脉高压症是一种微创、安全、有效的方法。Objective To discuss the availability and safety of the intracavitary therapy for prehepatic portal hypertension.Methods During Jan 2018 to Feb 2018,19 patients who had prehepatic portal vein are cured by interventional therapy,which is percutaneous transhepatic or percutaneous splenic.If necessary,use the spring ring to do the fund us of stomach esophagus EV embolism.Results Twelve patients is percutaneous transhepatic,7 patients is percutaneous splenic.After the treatment,the bleeding stopped.Some of the patients have fever and stomachache,but get better after special treatment within 7~14 days.19 patients all use the balloon dilatation for portal vein and put the covered stent in it.After interviewing the patients,the living time and quality are all better than the patients who didn’t get this treatment.Conclusion The intracavitary therapy for prehepatic portal hypertension is minimally invasive,effective and safe.

关 键 词：肝前性门脉高压 球囊扩张 支架 弹簧圈 

分 类 号：R657.34[医药卫生—外科学]